8.2.6Topic 8 · Grey Matter
Imbalances in Brain Chemicals Leading to Diseases — Edexcel A Level Biology A (SNAB) 9BI0 Revision Notes & Topical Questions
5 min read 9 parts Lesson 17 of 22 1 quiz
8.2.6 Imbalances in Brain Chemicals Leading to Diseases — Edexcel A Level Biology A (SNAB) 9BI0 notes: Explain how changes in the amount or action of neurotransmitters such as dopamine and serotonin are linked to Parkinson's disease and depression.Neurones communicate across syna…
- Exam-style question 1
- Exam-style question 2
- Exam-style question 3
- Blood-brain barrier
- If any part of this changes, the brain's chemistry is unbalanced and behaviour or movement can be affected
- It has been linked to low levels of serotonin (and related transmitters) at synapses in certain brain areas
Section 1 of 9Neurotransmitters and their balance
Neurones communicate across synapses by releasing neurotransmitters, which bind to receptors on the postsynaptic membrane.
Section 2 of 9Parkinson's disease and dopamine
Parkinson's disease is a progressive condition in which neurones in a part of the midbrain, the substantia nigra, die. These neurones release dopamine in the basal ganglia, which help control voluntary movement. With less dopamine, signals that start and smooth movement are reduced. Symptoms include tremor, muscle rigidity, slow movement and difficulty starting to move.
Treatment commonly uses L-dopa, a precursor of dopamine that crosses the blood-brain barrier and is converted to dopamine in the brain. Dopamine itself cannot cross the barrier. Other drugs act as dopamine agonists or inhibit the enzyme that breaks down dopamine. They relieve symptoms but do not cure the disease, and over time they become less effective.
Section 3 of 9Depression and serotonin
Depression is a mood disorder with persistent low mood and loss of interest.
The link is not simple
- SSRIs raise serotonin quickly but mood improves only after weeks, and not all patients respond.
- Genes, environment and life events also influence depression, so serotonin level is a risk factor, not the single cause.
Section 4 of 9Other examples and interpretation
When interpreting data on transmitter levels, look for correlation with symptoms, consider sample size, and remember that a correlation does not prove a causal link. Measurements are often made after death or by imaging, which have their own limitations.
Section 5 of 9Links
This topic links to synaptic transmission, the effect of drugs on synapses and personalised medicine, where a patient's genes affect the response to a drug.
Section 6 of 9Alzheimer's disease, schizophrenia and the limits of the chemical explanation
Other brain diseases also show chemical changes.
- although they do not stop the disease.
In schizophrenia, overactivity of dopamine pathways is thought to contribute to hallucinations and delusions.
- which raise dopamine, can produce similar symptoms,
- while antipsychotic drugs that block dopamine receptors reduce them.
- so other transmitters, including glutamate, are probably involved.
These examples teach an important point about scientific reasoning.
- and mention that genetics, environment and development influence all these diseases.
Nerve cells in the brain can also be affected by too much transmitter. Excess glutamate can overstimulate and damage neurones, which is thought to contribute to damage after a stroke. This shows that balance, rather than simply more or less, is what matters in a healthy brain.
Section 7 of 9Exam-style questions
Explain how a lack of dopamine causes the symptoms of Parkinson's disease. [3]3 marks
Neurones in the substantia nigra die so less dopamine is released at synapses [1]. Basal ganglia pathways controlling movement are less stimulated [1]. This causes tremor, rigidity and difficulty starting movement [1].
Explain why L-dopa is given instead of dopamine. [2]2 marks
Dopamine cannot cross the blood-brain barrier [1]. L-dopa can cross and is converted to dopamine in the brain [1].
Describe how an SSRI works. [3]3 marks
It blocks the reuptake transporters on the presynaptic membrane [1]. Serotonin stays in the synaptic cleft longer [1]. More receptors on the postsynaptic membrane are stimulated, increasing the effect [1].
Section 8 of 9Key terms
| Term | Meaning |
|---|---|
| Dopamine | Neurotransmitter involved in movement and reward |
| Serotonin | Neurotransmitter involved in mood and sleep |
| SSRI | Drug that blocks the reuptake of serotonin |
| L-dopa | Precursor of dopamine used to treat Parkinson's disease |
| Reuptake | Return of neurotransmitter from the cleft into the presynaptic neurone |
| Blood-brain barrier | Selective barrier between blood and brain tissue |
Section 9 of 9Exam technique
Marked practiceQuizzes for this lesson
Last updated: